The Economics of Home Dialysis: Acting for the Individual While Planning Responsibly for the Population

Advances in Chronic Kidney Disease

Volumn 16, Issue 3, 2009, Pages 198-204

  Komenda, Paul ^a   Sood, Manish M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Economic evaluation; Health policy; Home dialysis

Indexed keywords

ARTICLE; DECISION MAKING; ECONOMICS; HEALTH CARE COST; HOME DIALYSIS; HUMAN; KIDNEY FAILURE; MORTALITY; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

HEALTH POLICY; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS;

EID: 64849097579     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2009.02.006     Document Type: Article

References (46)

1. Blagg C. What went wrong with home hemodialysis in the United States and what can be done now?. Hemodial Int 4 (2000) 55-58
2. Retting R., and Levinsky N. Kidney Failure and the Federal Government (1991), National Academy Press, Washington, DC
3. United States Renal Data System (USRDS) 2003 Annual Data Report. International Comparisons. Atlas of End Stage Renal Disease in the United States (2007), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD pp 111-122
4. Grassman A., Gioberge S., Moeller S., et al. ESRD patients in 2004: Global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20 (2005) 2587-2593
5. Blake P.G. The complex economics of modality selection. Perit Dial Int 24 (2004) 509-511
6. United States Renal Data System (USRDS). Annual Data Report: Atlas of End Stage Renal Disease in the United States (2007), National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD pp 223-238
7. Lysaght M.J. Maintentance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 13 suppl 1 (2002) S37-S40
8. Neil N, Walker DR, Sesso R, et al: Gaining efficiencies: Resources and demand for dialysis around the globe. Value Health 2008 [Epub ahead of print]
9. Evans R.W. Health care technology and the inevitability of resource allocation and rationing decisions. Part I. JAMA 249 (1983) 2047-2053
10. Evans R.W. Health care technology and the inevitability of resource allocation and rationing decisions. Part II. JAMA 249 (1983) 2208-2219
11. Drummond M., Shulper M.J., Torrance G.W., et al. Methods for the Economic Evaluation of Health Care Programmes (ed 3) (2005), Oxford University Press, Oxford
12. Blake P.G. Integrated end-stage renal disease care: The role of peritoneal dialysis. Nephrol Dial Transplant 16 suppl 5 (2001) 61-66
13. Bloembergen W.E., Port F.K., Mauger E.A., et al. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6 (1995) 177-183
14. Fenton S.S., Schaubel D.E., Desmeules M., et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 30 (1997) 334-342
15. Ganesh S.K., Hulbert-Shearon T., Port F.K., et al. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14 (2003) 415-424
16. Stack A.G., Molony D.A., Rahman N.S., et al. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 64 (2003) 1071-1079
17. Termorshuizen F., Korevaar J.C., Dekker F.W., et al. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 14 (2003) 2851-2860
18. Vonesh E.F., and Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritioneal dialysis. J Am Soc Neprol 10 (1999) 354-365
19. Goeree R., Manalich J., Grootendorst P., et al. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 18 (1995) 455-464
20. Peeters P., Rublee D., Just P., et al. Analysis and interpretation of cost data in dialysis. Review of Western European literature. Health Pol 54 (2000) 200-227
21. De Vecchi A.F., Dratwa M., and Wiedemann M.E. Healthcare systems and end-stage renal disease (ESRD) therapies-An international review: Costs and reimbursement/funding of ESRD therapies. Neprhol Dial Transplant 14 suppl 6 (1999) 31-41
22. Sennfalt K., Magnusson M., and Carlsson P. Comparison of hemodialysis and peritoneal dialysis-A cost utility analysis. Perit Dial Int 22 (2002) 39-47
23. Mendelssohn D.C., Langlois N., and Blake P.G. Peritoneal dialysis in Ontario: A natural experiment in physician reimbursement methodology. Perit Dial Int 24 (2004) 531-537
24. British Columbia Renal Agency, Dialysis Status Reports 2006-2007. Available at: http://www.bcrenalagency.ca. Accessed December 10, 2007
25. Ayus J.C., Mizani M.R., Achinger S.G., et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 16 (2005) 2778-2788
26. Bolgg A., and Hyde C. Enhancing lifestyle through home haemodialysis. EDTNA ERCA J 32 (2006) 179-182
27. Chan C.T., Floras J.S., Miller J.A., et al. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17 (2002) 1518-1521
28. Chan C.T., Floras J.S., Miller J.A., et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61 (2002) 2235-2239
29. Chan C.T., Harvey P.J., Picton P., et al. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 42 (2003) 925-931
30. Chan C.T., Notarius C.F., Merlocco A.C., et al. Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant 22 (2007) 3285-3291
31. Culleton B.W., Klarenbach M., Mortis S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA 298 (2007) 1291-1300
32. Finkelstein F.O., Finkelstein S.H., Wuerth D., et al. Effects of home hemodialysis on health-related quality of life measures. Semin Dial 20 (2007) 265-268
33. Suri R.S., Nesrallah G.E., Mainra R., et al. Daily hemodialysis: A systematic review. Clin J Am Soc Nephrol 1 (2006) 33-42
34. Walsh M., Culleton B., Tonelli M., et al. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral meabolism, and health-related quality of life. Kidney Int 67 (2005) 1500-1508
35. Lee H., Manns B., Taub K., et al. Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 40 (2002) 611-622
36. Kroeker A., Clark W.F., Heidenheim A.P., et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 42 1 suppl (2003) 49-55
37. Laupacis A., Keown P., Pus A., et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50 (1996) 235-242
38. Saloma J.A., Weinstien M.C., Hammitt J.K., et al. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA 290 (2003) 228-237
39. McFarlane P.A., Pierratos A., and Redelmeier D.A. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 62 (2002) 2216-2222
40. Agar J.W., Knight R.J., Simmonds R.E., et al. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis. Nephrology (Carlton) 10 (2005) 557-570
41. Mohr P.E., et al. The economics of daily dialysis. Adv Ren Replace Ther 8 (2001) 273-279
42. Komenda P., Levin A., and Manns B. The economics of home nocturnal hemodialysis: How should we cost the benefits?. Clin Nephrol 68 (2007) 151-158
43. Komenda P., Copland M., Er L., et al. Outcomes of a provincial home haemodialysis programme-A two-year experience: Establishing benchmarks for programme evaluation. Nephrol Dial Transplant 23 (2008) 2647-2652
44. McFarlane P.A., Bayoumi A.M., Pierratos A., et al. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 64 (2003) 1004-1011
45. McFarlane P.A., Pierratos A., Bayoumi A.M., et al. Estimating preference scores in conventional and home nocturnal hemodialysis patients. Clin J Am Soc Nephrol 2 (2007) 477-483
46. Komenda P, Plamondon J: An evidence based approach to optimal and efficient care of CKD patients: Studying the Renal Health Clinic Flow. Manitoba Renal Program Conference Abstract, Winnipeg, Canada, Sept. 26-28, 2008